Stock Market Today: Nasdaq Notches Another High as COVID's Spread Worsens
An error in AstraZeneca's COVID-19 vaccine trial and persistent coronavirus troubles in the U.S. led investors to chase the old COVID trade Friday.


The broader markets closed the week with a passive partial session on Black Friday as setbacks in the fight against COVID challenged investors yet again to rethink their vigorous rotation into value stocks.
One worry: AstraZeneca's (AZN) admission that its scientists accidentally gave half-doses of its vaccine to one batch of volunteers – a mistake that could delay approval until more data can be gathered. Meanwhile, the U.S. tallied another 100,000 coronavirus cases on Thanksgiving and reported record hospitalizations (90,481) for the 17th consecutive day.
The Dow Jones Industrial Average finished up 0.1% to 29,910, while the Nasdaq Composite closed with a solid 0.9% gain to a record-high 12,205, led by Google parent Alphabet (GOOGL, +1.3%) and Netflix (NFLX, +1.3%).

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The Nasdaq also enjoyed a bump from Tesla (TSLA, +2.1%), whose shares have continued their wild 2020 rally amid broader enthusiasm for EV stocks, given what should be an accommodative Joe Biden administration. Tesla is now the sixth-largest U.S. stock at $555 billion in market value by virtue of passing Warren Buffett's Berkshire Hathaway (BRK.B, -0.7%, $543 billion) today.
Other action in the stock market today:
- The S&P 500 edged 0.2% higher to 3,638.
- The Russell 2000 improved by 0.6% to finish at 1,855, eclipsing its all-time high set on Tuesday.
- U.S. crude oil futures declined 0.9% to settle at $45.32 per barrel.
- Gold futures dipped heavily, sagging 2.4% to $1,788.10 per ounce.
Start Thinking About Your 401(k)
We're getting close to that time of year when even the least-active investors take a peek at their 401(k)s. For savvier Closing Bell readers, it's time to take a long, hard look at every investment in your 401(k) to make sure it's giving you the most bang for your buck.
We continue our series on 401(k) mutual-fund picks – which so far has included Vanguard, Fidelity and T. Rowe Price – with a look at the most popular 401(k) offerings from American Funds, whose managers are keenly aware of how much value they're adding.
Why? Because the culture of Capital Group, which manages the American Funds, includes having some skin in the game. As Kiplinger's senior associate editor Nellie Huang points out, "Many American Funds have at least one manager with more than $1 million of his or her own money invested in the portfolio."
Read on as we break down 14 American Funds that are commonly found in 401(k) plans, rating each one a Buy, Hold or Sell.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Kyle Woodley is the Editor-in-Chief of WealthUp, a site dedicated to improving the personal finances and financial literacy of people of all ages. He also writes the weekly The Weekend Tea newsletter, which covers both news and analysis about spending, saving, investing, the economy and more.
Kyle was previously the Senior Investing Editor for Kiplinger.com, and the Managing Editor for InvestorPlace.com before that. His work has appeared in several outlets, including Yahoo! Finance, MSN Money, Barchart, The Globe & Mail and the Nasdaq. He also has appeared as a guest on Fox Business Network and Money Radio, among other shows and podcasts, and he has been quoted in several outlets, including MarketWatch, Vice and Univision. He is a proud graduate of The Ohio State University, where he earned a BA in journalism.
You can check out his thoughts on the markets (and more) at @KyleWoodley.
-
The AI Doctor Coming to Read Your Test Results
The Kiplinger Letter There’s big opportunity for AI tools that analyze CAT scans, MRIs and other medical images. But there are also big challenges that human clinicians and tech companies will have to overcome.
By John Miley Published
-
The Best Places for LGBTQ People to Retire Abroad
LGBTQ people can safely retire abroad, but they must know a country’s laws and level of support — going beyond the usual retirement considerations.
By Drew Limsky Published
-
Stock Market Today: Tariff Talks Drive Another Up-and-Down Day
Trade war negotiations are happening, but the "fear gauge" is gyrating, and investors, traders and speculators are still searching for signs of a bottom.
By David Dittman Published
-
Stock Market Today: Dow Drops Another 2,231 Points to Hit a Correction
The Nasdaq Composite, meanwhile, entered a new bear market with its latest slide.
By Karee Venema Published
-
Stock Market Today: Dow Dives 1,679 Points on Trump Tariff Shock
U.S. stocks lost roughly $3.1 trillion in market cap on Thursday – the biggest one-day decline since the start of the COVID-19 pandemic in March 2020.
By Karee Venema Published
-
The Stock Market Is Selling Off. Here's What Investors Should Do
Investors started fleeing the equities market en masse in response to the Trump administration's "jaw-dropping" tariffs. But the experts say don't panic.
By Karee Venema Last updated
-
Stock Market Today: It's the Old Up-Down Again on Liberation Day
Markets look forward to what comes with the reordering of 80-year-old global trade relationships.
By David Dittman Published
-
Stock Market Today: Stocks Are Mixed Before Liberation Day
Markets are getting into the freewheeling rhythm of a second Trump administration.
By David Dittman Published
-
How to Invest in Sports
If it's springtime, Forbes is out with its annual list of baseball franchise values. The billions involved might make you wonder how to invest in sports.
By David Dittman Published
-
Stock Market Today: It's Going to Stay Choppy for Stocks
Auto-focus can show us a lot about uncertainty on the ground and in the stock market.
By David Dittman Published